Public Announcement of the Environmental Impact Assessment Report for the Generic Drug R&D Project of Beijing Haibu Pharmaceutical Technology Co., Ltd.
Classification:
Company News
Release time:
2020-07-10
According tothe 'Guidelines for the Public Disclosure of Government Information on Environmental Impact Assessment of Construction Projects (Trial)',the environmental impact report for the generic drug R&D project of Beijing Haibu Pharmaceutical Technology Co., Ltd. is now publicly disclosed as follows:
Public disclosure content: Environmental impact report for the generic drug R&D project of Beijing Haibu Pharmaceutical Technology Co., Ltd., see the extraction link below.
Project name: Generic drug R&D project of Beijing Haibu Pharmaceutical Technology Co., Ltd.
Construction location: No. 156, Jinghai Fourth Road, Economic and Technological Development Zone, Beijing, Building 13, Jinghai Industrial Park
Construction unit: Beijing Haibu Pharmaceutical Technology Co., Ltd.
Contact information for the construction unit
Contact person: Xie Chao
Contact phone number: 13051293230
Contact address: No. 156, Jinghai Fourth Road, Economic and Technological Development Zone, Beijing, Building 13, Jinghai Industrial Park
Contact information for the environmental assessment unit
Environmental assessment unit: Pony Testing Group Co., Ltd.
Contact person: Engineer Ji
Contact phone number: 010-83055000
Contact address: Pony Testing Building, No.1 Building, No.66 Jindai Road, Haidian District, Beijing
Link to extract the environmental assessment report:[https://pan.baidu.com/s/1swTxqcsg03wKnClXsp9xiQ](https://pan.baidu.com/s/1swTxqcsg03wKnClXsp9xiQ)
提取码：217v
Limited company, pharmaceuticals, technology shares, project, research and development, manufacturing, contact person, unit, Jinghai
Beijing Hope Pharmaceutical Co., Ltd.
